 |
||
 |
 |
 |
|
|
| Our Team | |
Paul Rosenberg, M.D. Email Address: prosenb9@jhmi.edu 
Mielke M, Rosenberg P, Tschanz J, Cook L, Corcoran C, Hayden K, Norton M, Rabins P, Green R, Welsh-Bohmer K, Breitner J, Munger R, Lyketsos C. Vascular factors predict rate of progression in Alzheimer’s disease. Neurol 2007; 69: 1850-1858. Martin B, Frangakis C, Rosenberg P, Mintzer J, Katz I, Porsteinsson A, Schneider L, Rabins P, Munro C, Meinert C, Niederehe G, Lykestsos C. Design of Depression in Alzheimer’s Disease Study – 2. Am J Geriatr Psychiatry 2006; 14: 920-930. Rao V, Spiro J, Rosenberg P, Lee H, Rosenblatt A, Lyketsos C. An open-label study of escitalopram (Lexapro) for treatment of depression in Alzheimer’s Disease (dAD). Int J Geriatr Psychiatry 2006; 21: 273-274.
Rosenberg P, Mielke M, Lyketsos C. Caregiver assessment of patients’ depression in Alzheimer’s disease: longitudinal analysis of a drug treatment study. Am J Geriatr Psychiatry 2005; 13: 822-826.
|
